The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| WAT | +2.72% | +57.09% | +9.45% | +9,136% |
| S&P | +14.5% | +93.32% | +14.09% | +1,016% |
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
The healthcare company's second-quarter results appear better than expected.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $771.33M | 8.9% |
| Gross Profit | $438.00M | 7.5% |
| Gross Margin | 56.79% | -0.7% |
| Market Cap | $20.77B | 20.7% |
| Market Cap / Employee | $2.73M | 0.0% |
| Employees | 7.6K | -3.8% |
| Net Income | $147.11M | 3.1% |
| EBITDA | $239.85M | 0.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $367.22M | 12.5% |
| Accounts Receivable | $730.07M | 19.7% |
| Inventory | 540.8 | 3.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.25B | -39.4% |
| Short Term Debt | $288.75M | 995.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 14.43% | 1.2% |
| Return On Invested Capital | 28.12% | -4.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $18.55M | 0.6% |
| Operating Free Cash Flow | $41.14M | -24.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 34.10 | 34.63 | 32.84 | 31.77 | 9.91% |
| Price to Book | 15.13 | 13.74 | 11.97 | 10.58 | -22.72% |
| Price to Sales | 7.32 | 7.48 | 7.25 | 6.90 | 15.11% |
| Price to Tangible Book Value | -44.30 | -74.56 | -623.27 | 204.36 | -874.86% |
| Price to Free Cash Flow TTM | 34.29 | 35.71 | 34.92 | 33.94 | 10.40% |
| Enterprise Value to EBITDA | 87.12 | 68.69 | 112.64 | 92.54 | 16.07% |
| Free Cash Flow Yield | 2.9% | 2.8% | 2.9% | 2.9% | -9.42% |
| Return on Equity | 49.6% | 42.8% | 40.8% | 37.0% | -32.13% |
| Total Debt | $1.90B | $1.70B | $1.54B | $1.54B | -26.35% |
WAT earnings call for the period ending September 30, 2021.
WAT earnings call for the period ending June 30, 2021.
WAT earnings call for the period ending March 31, 2021.
WAT earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
